1.
Journal of Korean Society of Endocrinology
;
: 519-523, 2005.
Artículo
en Coreano
| WPRIM
| ID: wpr-115699
RESUMEN
Methimazole is a widely used and generally well-tolerated antithyroid agent. Adverse reactions occur in 1~5% of patients taking methimazole medication, but these are most commonly transient, benign leukopenia and a skin rash. Severe cholestatic jaundice, combined with agranulocytosis, has been known as a rare complication. Herein, a case of methimazole induced cholestatic jaundice, with agranulocytosis, is reported.